-
Signature
-
/s/ David Kwon
-
Issuer symbol
-
ADP
-
Transactions as of
-
02 Jan 2024
-
Net transactions value
-
-$614,490
-
Form type
-
4
-
Filing time
-
04 Jan 2024, 16:11:06 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ADP |
Common Stock |
Options Exercise |
$209,559 |
+1,428 |
+18% |
$146.75 |
9,587 |
02 Jan 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Options Exercise |
$128,820 |
+1,200 |
+13% |
$107.35 |
10,787 |
02 Jan 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
$93,352 |
-400 |
-3.7% |
$233.38 |
10,387 |
02 Jan 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
$229,179 |
-982 |
-9.5% |
$233.38 |
9,405 |
02 Jan 2024 |
Direct |
F1 |
| transaction |
ADP |
Common Stock |
Sale |
$291,958 |
-1,251 |
-13% |
$233.38 |
8,154 |
02 Jan 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
$128,820 |
-1,200 |
-50% |
$107.35 |
1,200 |
02 Jan 2024 |
Common Stock |
1,200 |
$107.35 |
Direct |
|
| transaction |
ADP |
Stock Option (Right to Buy) |
Options Exercise |
$209,559 |
-1,428 |
-100% |
$146.75 |
0 |
02 Jan 2024 |
Common Stock |
1,428 |
$146.75 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: